Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-12

FDA Approved: DIFAMILAST — Original Application (Acrotech Biopharma Inc)

View source ↗

Summary

FDA approved the original application for Difamilast (ADQUEY) from Acrotech Biopharma Inc. for the treatment of atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIFAMILAST (ADQUEY)

Snippet

ORIG AP for DIFAMILAST (ADQUEY)